/LVVV
LVVV Stock - LiveWire Ergogenics, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+33.33%
+$0.00 (+33.33%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.60
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for LVVV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.39
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $304,119 | $1.63M | $1.94M | $851,199 | $580,315 |
| Gross Profit | $285,162 | $1.59M | $1.80M | $701,553 | $376,506 |
| Gross Margin | 93.8% | 97.6% | 93.1% | 82.4% | 64.9% |
| Operating Income | $119,413 | $829,986 | $644,730 | $-2,490,000 | $-465,000 |
| Net Income | $78,725 | $921,575 | $684,124 | $-3,432,000 | $-1,601,000 |
| Net Margin | 25.9% | 56.4% | 35.3% | -403.2% | -275.9% |
| EPS | $0.00 | $0.00 | $0.00 | $-0.00 | $-0.00 |
Company Overview
LiveWire Ergogenics Inc. focuses on acquiring, managing, and licensing special purpose real estate properties to produce handcrafted and organically grown cannabis products for medical and recreational adult-use in California. The company is based in Anaheim, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
LVVVBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q2 2024
EPS Surprise History
Q2 22
No data
Q4 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 30, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q1 2025 | Mar 26, 2025 | — | — | — | — |
Q4 2024 | Dec 27, 2024 | — | — | — | — |
Q3 2024 | Aug 26, 2024 | — | — | — | — |
Q2 2024 | May 22, 2024 | — | — | — | — |
Q2 2024 | Apr 2, 2024 | — | $0.00 | — | — |
Q4 2023 | Nov 20, 2023 | — | $0.00 | — | — |
Q3 2023 | Aug 21, 2023 | — | $0.00 | — | — |
Q2 2023 | May 19, 2023 | — | $0.00 | — | — |
Q1 2023 | Mar 28, 2023 | — | $0.00 | — | — |
Q4 2022 | Dec 30, 2022 | — | $0.00 | — | — |
Q4 2022 | Nov 16, 2022 | — | $0.00 | — | — |
Q2 2022 | May 17, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 29, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 18, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 30, 2021 | — | — | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about LVVV
What is LVVV's current stock price?
LiveWire Ergogenics, Inc. (LVVV) is currently trading at $0.00 per share. The stock has moved +33.33% today.
What is the analyst price target for LVVV?
No analyst price targets are currently available for this stock.
What sector is LiveWire Ergogenics, Inc. in?
LiveWire Ergogenics, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is LVVV's market cap?
LiveWire Ergogenics, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does LVVV pay dividends?
No, LiveWire Ergogenics, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANTCF
Aion Therapeutic Inc.
$0.00
Mkt Cap: $0.0B
CVGRF
City View Green Holdings Inc.
$0.05
Mkt Cap: $0.0B
EVIO
EVIO, Inc.
$0.00
Mkt Cap: $0.0B
GENPF
Genix Pharmaceuticals Corporation
$0.03
Mkt Cap: $0.0B
HEMP
Hemp, Inc
$0.00
Mkt Cap: $0.0B
IGEX
Indo Global Exchange(s) PTE, Ltd.
$0.00
Mkt Cap: $0.0B
KAYS
Kaya Holdings, Inc.
$0.04
Mkt Cap: $0.0B
LVRLF
CordovaCann Corp.
$0.03
Mkt Cap: $0.0B
MCOA
Marijuana Company of America, Inc.
$0.00
Mkt Cap: $0.0B
TLLTF
TILT Holdings Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to LVVV for comparison